BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30336731)

  • 1. Lifestyle changes associated with participation in colorectal cancer screening: Prospective data from the English Longitudinal Study of Ageing.
    Stevens C; Smith SG; Vrinten C; Waller J; Beeken RJ
    J Med Screen; 2019 Jun; 26(2):84-91. PubMed ID: 30336731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
    Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
    Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women.
    Blanks RG; Benson VS; Alison R; Brown A; Reeves GK; Beral V; Patnick J; Green J
    Br J Cancer; 2015 Apr; 112(9):1562-7. PubMed ID: 25742470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle and occupational factors associated with participation in colorectal cancer screening among men and women in Australia.
    Carey RN; El-Zaemey S
    Prev Med; 2019 Sep; 126():105777. PubMed ID: 31319115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.
    He E; Alison R; Blanks R; Pirie K; Reeves G; Ward RL; Steele R; Patnick J; Canfell K; Beral V; Green J
    Int J Epidemiol; 2019 Apr; 48(2):549-558. PubMed ID: 30668711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
    Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
    J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
    Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
    Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer.
    Cole SR; Young GP
    Med J Aust; 2001 Aug; 175(4):195-8. PubMed ID: 11587278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test.
    Botteri E; Crosta C; Bagnardi V; Tamayo D; Sonzogni AM; De Roberto G; de Leone A; Lowenfels A; Maisonneuve P
    Dig Liver Dis; 2016 Mar; 48(3):321-6. PubMed ID: 26739617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
    Bae N; Park S; Lim S
    Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing participation in colorectal cancer screening programs in Spain.
    Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
    Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.